How much is Oncopia Therapeutics worth in 2026?

Oncopia Therapeutics has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Oncopia Therapeutics raised?

Oncopia Therapeutics has raised N/A in total funding across 1 funding rounds.

Oncopia Therapeutics

Biotechnology

Oncopia Therapeutics valuation and funding history | Last updated: December 6, 2020 | 1 funding rounds

Current Valuation

N/A

As of December 6, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Dec 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 6, 2020	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Oncopia Therapeutics is currently valued at N/A as of December 6, 2020.

Track Oncopia Therapeutics Valuation Updates

Get notified when Oncopia Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Oncopia Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Oncopia Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Oncopia Therapeutics Worth in 2026?

Oncopia Therapeutics is a leading private company in the Biotechnology sector. Track Oncopia Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Oncopia Therapeutics Valuation is Determined

Private company valuations like Oncopia Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.